{"id":16470,"date":"2026-01-14T12:38:00","date_gmt":"2026-01-14T07:08:00","guid":{"rendered":"https:\/\/theeducationoverview.in\/?p=16470"},"modified":"2026-01-14T12:38:11","modified_gmt":"2026-01-14T07:08:11","slug":"india-medtech-expo-2025-showcased-end-to-end-medtech-ecosystem-reinforcing-indias-position-as-a-global-medtech-innovation-hub","status":"publish","type":"post","link":"https:\/\/theeducationoverview.in\/?p=16470","title":{"rendered":"India Medtech Expo 2025 showcased End-To-End Medtech Ecosystem Reinforcing India\u2019s Position as a Global Medtech Innovation Hub"},"content":{"rendered":"<div class=\"text-center event-heading-background\">\n<h2 id=\"Titleh2\" style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>India Medtech Expo 2025 showcased End-To-End Medtech Ecosystem Reinforcing India\u2019s Position as a Global Medtech Innovation Hub<\/strong><\/span><\/h2>\n<h3 style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong><br \/>\nPradhan Mantri Bhartiya Janaushadhi Pariyojana Register Sales of \u20b9 1409.32 cr till November 2025; Online Web Portal revamped for seamless form filling and Live Tracking with Geo-Tagging;<\/strong><\/span><\/h3>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>Under PLI Scheme for Pharmaceuticals, \u20b940,294cr worth investment made; 726 APIs \/ KSMs \/ DIs manufactured including 191 for the first time<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>NIPERs continue to be ranked among the top 30 Pharmacy Institutes in the Country; 40 Faculty Members figure in the prestigious Stanford Top 2% Scientists List<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>Under Promotion of Research and Innovation in Pharma Medtech Sector (PRIP) Scheme- Centres of Excellences approve 111 Research Projects and Evaluation of applications for Financial Assistance for Research in Pharma-Medtech Sector underway<\/strong><\/span><\/p>\n<\/div>\n<div id=\"PrDateTime\" class=\"ReleaseDateSubHeaddateTime text-center pt20\" style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>Posted On: 06 JAN 2026 5:02PM by PIB Delhi<\/strong><\/span><\/div>\n<div class=\"pt20\" style=\"text-align: justify;\"><\/div>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>The major initiatives and achievements of\u00a0Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers during the year 2025 are as under:<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>Implemented through Pharmaceuticals &amp; Medical Devices Bureau of India (PMBI),<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>a total of 17,610 Jan Aushadhi Kendras have been opened so far including 2202 in 2025.\u00a0Product basket of PMBJP comprises 2110 medicines, 315 medical devices and consumables covering 29 therapeutic groups such as Anti-infectives, Anti-diabetics, Cardiovascular, Anti-cancers, Gastro-intestinal medicines, etc.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>Jan Aushadhi Suvidha Sanitary Napkins at \u20b91\/- per pad are made available through JAKs.\u00a0 Over 96.30 crore Suvidha Sanitary Pads have been sold so far and out of this, over 17.90 crore were sold in 2025.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>In 2024-25, PMBI registered sales of \u20b92022.47 crore which led to savings of approximately \u20b98000 crore to the citizens. In the current financial year 2025-26, till 30.11.2025, PMBI has made sales of \u20b91409.32 crore, which has led to savings of approximately \u20b95637 crore to the citizens.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>Progress Report\u00a0(As on 30.11.2025)<\/strong><\/span><\/p>\n<div class=\"table-responsive\" style=\"text-align: justify;\">\n<table class=\"Table\" border=\"1\" cellspacing=\"0\" cellpadding=\"5\" align=\"center\">\n<tbody>\n<tr>\n<td rowspan=\"2\"><span style=\"color: #3366ff;\"><strong>Financial Year<\/strong><\/span><\/td>\n<td colspan=\"2\"><span style=\"color: #3366ff;\"><strong>Number of JAKs functional<\/strong><\/span><\/td>\n<td rowspan=\"2\"><span style=\"color: #3366ff;\"><strong>Sales at MRP Value in \u20b9 crore<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>Yearly addition<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>Cumulative<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>2024-25<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>4142<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>15,403<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>2022.47<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>2025-26<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>2207<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>17,610<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>1409.32<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>New Initiatives:<\/strong><\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>The revamping of the online application portal. An easy web and mobile based Graphical User Interface (GUI) enable seamless form filling, document uploading, and live tracking with the added geo-tagging functionality for users.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>Jan Aushadhi Kendra applicants and Jan Aushadhi Kendra owners can avail the benefits of business activity loan under Pradhan Mantri Mudra Yojana of up to \u20b920 lakhs by registering themself at &#8220;Jan Samarth Portal&#8221;.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>Expansion of distributor network from 36 distributors to 39 distributors.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong><em>To enhance warehouse inward efficiency and capacity within the supply chain management, the DWS (Dimensioning, Weighing and Scanning) system has been deployed. This enables faster receiving through automatic capture of dimensions, weight, and barcode data in seconds; boosts throughput for higher carton volumes per hour; ensures improved accuracy by eliminating manual errors in measurements and Stock Keeping Units (SKU) identification; provides seamless real-time integration with the Warehouse Management System (WMS) for efficient put-away decisions; and optimises space utilization with precise dimensional data for better storage planning. This new system will enable the warehouses to handle greater volumes with the same resources while maintaining data integrity.<\/em><\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>Pradhan Mantri Bhartiya Janaushadhi Pariyojana participated in two major events in New Delhi: the India Med Tech Expo 2025 and the 44<sup>th<\/sup>\u00a0India International Trade Fair (IITF) 2025 at Pragati Maidan.<\/strong><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong><img decoding=\"async\" id=\"Picture_x0020_1\" src=\"https:\/\/static.pib.gov.in\/WriteReadData\/userfiles\/image\/image001M8FA.jpg\" \/><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Reducing import dependence for bulk drugs:<\/strong><\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>Under PLI scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)\/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs), 35 projects have been commissioned for manufacturing of 26 APIs\/KSMs, including fermentation-based products such as Penicillin-G, Clavulanic acid and Rifampicin, which were earlier primarily imported.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>As of September 2025, against targeted investment of \u20b94,330 crore, investment worth \u20b94,763.34 crore has been made.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>As of September 2025, cumulative sales worth \u20b92,315.44 crore have been made under the scheme, including exports worth \u20b9508.12 crore, thereby avoiding imports worth \u20b91807.32 crore since inception of the scheme in FY2022-23.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>As of September 2025, an employment for 4,929 persons has been generated<\/strong><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Enhancing India\u2019s manufacturing capabilities and exports in the pharmaceuticals sector:<\/strong><\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>Under the PLI Scheme for Pharmaceuticals, investment worth \u20b940,294 crore has been made as of September 2025, significantly exceeding the targeted investment of \u20b917,275 crore.\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>The scheme supports manufacturing of high-value products like biopharmaceuticals, complex generics, patented\/off-patent drugs, orphan, and autoimmune drugs, generating total sales of \u20b93,08,408.60 crore, including \u20b91,98,509.49 crore in exports since inception till September 2025.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>Against the expected direct employment for 20,000 persons employment has already been generated for approximately 97,000 persons, including contractual and apprentice workers by September, 2025 since inception.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>Production is taking place through over 350 manufacturing units, including 28 greenfield locations which have been established under this scheme.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>726 APIs \/ KSMs \/ DIs are being manufactured under the scheme, including 191 which have been manufactured for the first time under the scheme.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>30% of India\u2019s overall bulk drug exports and 26.5% of overall formulation exports in FY 2025 has been contributed through production under the scheme.<\/strong><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Scheme for Strengthening of Pharmaceutical Industry (SPI):<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>The Central Sector Scheme \u201cStrengthening of Pharmaceutical Industry\u201d (SPI), comprises of the following sub-schemes:<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>(i) Assistance to Pharmaceutical Industry for Common Facilities (API-CF),\u00a0to strengthen the existing pharmaceutical clusters\u2019 capacity for their sustained growth by creating common facilities. Under the Scheme, as November 2025, 8 projects have been given final approval.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>(ii) Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS):\u00a0Under the scheme, as of 30.11.2025, 433 registrations have been made and 380 applications have been received. Out of these 380 applications, Scheme Steering Committee has approved 192 applications including 167 applications in Financial Year 2025-26.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>(iii) Pharmaceutical and Medical Devices Promotion and Development Scheme (PMPDS)\u00a0Under this\u00a063 events\/workshops\/seminars\/webinars and 24 studies have been carried out as on November-2025.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>5. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Scheme for Promotion of Bulk Drug Parks:<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>Under the scheme the Department had received proposals from 13 states. After evaluation, proposals of Gujarat, Himachal Pradesh and Andhra Pradesh were approved. \u20b91000 crore grant has been approved for each of the selected State. Construction activities are in progress in all 3 selected parks. The status of funds released and utilised in the selected Bulk Drug parks is as under:<\/strong><\/span><\/p>\n<div style=\"text-align: justify;\">\n<div class=\"table-responsive\">\n<table class=\"Table\" border=\"1\" cellspacing=\"0\" cellpadding=\"5\" align=\"center\">\n<tbody>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>States<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>Total Project Cost<\/strong><\/span><\/p>\n<p><span style=\"color: #3366ff;\"><strong>(in\u00a0\u20b9\u00a0crore)<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>Total<\/strong><\/span><\/p>\n<p><span style=\"color: #3366ff;\"><strong>CIF Cost<\/strong><\/span><\/p>\n<p><span style=\"color: #3366ff;\"><strong>(in\u00a0\u20b9\u00a0crore)<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>Central Grants released (in\u00a0\u20b9\u00a0crore)<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>State Fund<\/strong><\/span><\/p>\n<p><span style=\"color: #3366ff;\"><strong>Released (in\u00a0\u20b9\u00a0crore)<\/strong><\/span><\/p>\n<p>&nbsp;<\/td>\n<td><span style=\"color: #3366ff;\"><strong>Funds utilised till November 2025 including State Share (in\u00a0\u20b9\u00a0crore)<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>Gujarat<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>2507.02<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>1457.01<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>600.00<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>137.10<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>427.92<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>Himachal Pradesh<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>1923<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>1118.46<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>225.00<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>35.54<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>50.76<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>Andhra Pradesh<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>1876.66<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>1438.89<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>225.00<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>132.30<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>268.75<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical Devices:<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>This scheme intends to boost domestic manufacturing and attract large investments in the medical devices sector.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>The products under the scheme have been categorised under following four categories:<\/strong><\/span><\/p>\n<ol style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>Cancer care \/ Radiotherapy medical devices<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>Radiology and imaging medical devices (both ionising &amp; non-ionising radiation products) and nuclear imaging devices<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>Anesthetics and cardio-respiratory medical devices including catheters of cardio respiratory category and renal care medical devices<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>All implants including implantable electronic devices<\/strong><\/span><\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>The cumulative sales made by the applicants under the scheme is \u20b912,344.37 crore (which included exports worth \u20b95,869.36 crore) upto September 2025.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Common Facilities for Medical Devices Clusters (CFMDC) Scheme for\u00a0\u00a0strengthening the existing and new Medical Device clusters by providing financial assistance for Common Infrastructure Facilities and improve availability of more Medical Device Testing Laboratories.<\/strong><\/span><\/p>\n<div class=\"table-responsive\" style=\"text-align: justify;\">\n<table class=\"Table\" border=\"1\" cellspacing=\"0\" cellpadding=\"5\" align=\"center\">\n<tbody>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>Particulars<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>No.<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>Grant-in-Aid (\u20b9 crore)<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>In-principle approval<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>10<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>90.92<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>Final Approval<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>7<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>40.72<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>Disbursement<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>7<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>10.18<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>Final approval i.r.o 2 cases proposed to be approved in next SSC.<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>2<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>31.71<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"color: #3366ff;\"><strong>Balance available under the Scheme<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>&#8211;<\/strong><\/span><\/td>\n<td><span style=\"color: #3366ff;\"><strong>37.57<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 India MedTech Expo 2025<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>The India MedTech Expo 2025, the 2<sup>nd<\/sup>\u00a0International Exhibition on the Medical Devices Sector, with the theme \u201cGlobal MedTech Manufacturing Hub: Precision Engineering yet Affordable\u201d \u2013 reinforcing India\u2019s position as a global MedTech innovation hub was held from 4\u20136.9.2025 at Bharat Mandapam, Pragati Maidan, New Delhi. The event was inaugurated by Shri Piyush Goyal, Hon\u2019ble Minister of Commerce and Industry, Government of India, and was addressed by Shri Amit Agrawal, Secretary, Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>It showcased India\u2019s end-to-end MedTech ecosystem including Start-ups, Future Pavilion, R&amp;D Pavilion, MSMEs, large enterprises, R&amp;D institutions, hospitals and academia. It served as a catalyst for global collaboration, technology innovation, and investment, aligned with Government of India\u2019s Vision 2047 to establish India as a Global MedTech Hub.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>The event witnessed strong multi-stakeholder participation, with a total visitor footfall of 12,106 over three days and 2,980 B2B buyer\u2013seller meetings, indicating robust industry engagement and export potential. The exhibition featured 65 Indian and global companies, start-ups, and academic labs, along with 74 live and digital showcases in dedicated pavilions including the State Pavilion, R&amp;D Pavilion, Start-up Pavilion, and Future Pavilion. An International Buyer\u2013Seller Meet further strengthened trade linkages.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Strengthening of Medical Devices Industry (SMDI) Scheme:<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>(i) \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Capacity Building and Skill Development in Medical Device Sector Scheme (\u20b9100 crore)<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>The main objective of this sub-scheme is to fill the gap existing in the education and research in medical devices sector and to ensure quality teaching, training and nurturing excellence in Medical Technology education for generating critical mass of trained human resource to meet the requirements of rapidly innovating multidisciplinary areas of Medical Technology while facilitating R&amp;D ecosystem for the sector. Under the sub-scheme, In-principle approval has been granted to 13 proposals for Component-A and 5 proposals for Component-B.<a style=\"color: #3366ff;\" name=\"_heading=h.2uh7zvwojumo\"><\/a><a style=\"color: #3366ff;\" name=\"_heading=h.llz9fnq8vwn1\"><\/a>\u00a0Proposals\u00a0under\u00a0Component A for Masters Programs and Component B for Certificate\/PG Diploma have started\u00a0implementation, with student enrollment completed for the upcoming academic session.<a style=\"color: #3366ff;\" name=\"_heading=h.nrjf9flj2jb4\"><\/a><a style=\"color: #3366ff;\" name=\"_heading=h.66ryhs5bm9g2\"><\/a>\u00a0The approved programmes together provide for 750 seats.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>(ii) \u00a0\u00a0\u00a0\u00a0\u00a0 Marginal Investment Scheme for Reducing Import Dependence Scheme .(\u20b9180 crore)<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>The \u00a0objective of this sub-scheme is to promote domestic production of key components, raw materials and accessories used in manufacturing of medical devices, including in-vitro diagnostic devices, in order to reduce dependence of Indian medical device manufacturers on imported key components and raw materials and increase the depth of our value chains.\u00a0Under the scheme,\u00a0a\u00a0total of 15 applicants have been granted In-principle approval for approx. \u20b988 crore.\u00a0The application window for the sub-scheme has been reopened from 10.12.2025 to 10.1.2026, inviting fresh applications.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>(iii)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Medical Device Clinical Studies Support Scheme (\u20b9 100 crore)<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>The objective of this sub-scheme is to support the medical device industry by fostering development of devices supported by clinical evidence and generation of clinical data that demonstrates the safety and efficacy of the devices manufactured in India.\u00a0A total of 18 proposals have been\u00a0considered by the\u00a0SSC for\u00a0In-principle\u00a0approval.\u00a0The application window for the sub-scheme has been reopened from 10.12.2025 to 10.1.2026, inviting fresh applications.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>10.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Pharmaceutical is one of the top ten attractive sectors for foreign investment in India.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>During 2024-25, FDI inflows in pharmaceutical sector (both in pharmaceuticals and medical devices) was \u20b912,753 crore. During the current financial year of 2025-26 from April 2025 to up to September 2025, FDI inflows (both in pharmaceuticals and medical devices) has been \u20b913,193 crore, which was \u20b98,103 crore during the corresponding period of financial year 2024-25.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>11.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0MoU on Cooperation in the field of pharmaceuticals and medical device products between the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers of the Republic of India and the Ministry of Health, Welfare and Sports of the Netherlands\u00a0was signed on 19.6.2025.<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>The MoU focusses on cooperation in the field of pharmaceuticals and medical device products, to be implemented through a Joint Working Group (JWG).<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>12.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 National Institutes of Pharmaceutical Education and Research (NIPERs):<\/strong><\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>As per the National Institutional Ranking Framework (NIRF) of the Ministry of Education, under the \u2018Pharmacy\u2019 category, all seven NIPERs are ranked among the top 30 pharmacy institutes in the country, with Hyderabad ranked 5<sup>th<\/sup>, Mohali 9<sup>th<\/sup>, Guwahati 12<sup>th<\/sup>, Raebareli 17<sup>th<\/sup>, Ahmedabad 21<sup>st<\/sup>, Kolkata 29<sup>th<\/sup>\u00a0and Hajipur 30<sup>th\u00a0<\/sup>in NIRF, 2025.\u00a0They also rank high in terms of the calibre of their faculty, which includes 40 faculty members who figure in the prestigious Stanford Top 2% Scientists list.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>So far, 10,974 students have graduated from NIPERs, consisting of 721 doctoral students, 8,894 post graduates and 1359 MBA degree-holders.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>This is reflected in the high placement rates of NIPERs, which had an average placement rate of 89.28% this year i.e., 2025 for NIPER Ahmedabad, NIPER Hajipur and NIPER Raebareli. Placement at NIPER Mohali, Kolkata, Guwahati and Hyderabad is ongoing.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>As part of academia-industry linkage, as on 31.10.2025, NIPERs have signed 346 Memoranda of Understanding with industries and other academic institutions, filed 476 patents (of which 202 patents were granted and 11 patents are commercialised and published 8,766 research papers in reputed journals.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>During FY 2025-2026, as on 31.10.2025, 378 research papers were published, 33 patent filed and 22 Memoranda of Understanding signed by NIPERs.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>The construction of \u00a0campuses at Hyderabad, Kolkata, Raebareli and Hajipur are in progress. As on 31.10.2025, 72% of the construction work at NIPER Hajipur, 62% at NIPER Hyderabad, 73% at NIPER Kolkata, and 93% at NIPER Raebareli has been completed.<\/strong><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>Key highlights\/Achievements of the 7 NIPERs:<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>NIPER Ahmedabad<\/strong><\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>NIPER -Ahmedabad hosted an industry-academia interaction session on 18.1.2025 in the presence of Shri Jagat Prakash Nadda, Union Minister of Chemicals and Fertilizers and Health and Family Welfare.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>On 18.1.2025, Shri Jagat Prakash Nadda, Hon\u2019ble Union Minister of Union Minister of Chemicals and Fertilizers and Health and Family Welfare, laid the foundation stone for the Student Utility Centre at NIPER Ahmedabad.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>NIPER-A Testing Laboratory (NTL), nation&#8217;s first NABL accredited lab at NIPER-Ahmedabad for mechanical testing of medical devices (Hip Implant) was inaugurated<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>NIPER Ahmedabad, has made a strategic alliance with Trident Lifeline Limited, a dynamic and rapidly expanding Small and Medium Enterprise (SME). This partnership, formalized through a technology transfer agreement, marks a significant milestone in bringing the critical cancer drug Vorinostat to Indian patients.<\/strong><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>NIPER Guwahati<\/strong><\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>Atal Incubation Centre at NIPER Guwahati was inaugurated on 18.6.2025 and recognised as Host Institute under the Ministry of MSME, Government of India.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>The Department of Medical Chemistry of NIPER Guwahati has successfully synthesised 13 Reference molecules for human sports dope testing and provided National Dope Testing Laboratory (NDTL), New Delhi, under the Ministry of Youth Affairs and Sports, Government of India and accredited by World Anti-Doping Agency (WADA).<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>NIPER, Guwahati, has announced the launch of a one-year postgraduate diploma course in medical devices, commencing from the academic year 2025\u201326.<\/strong><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>NIPER Hajipur<\/strong><\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>Under National Pharmacovigilance Ranking\u00a0NIPER Hajipur consistently ranks among the Top 10 performing centres in India contributing to both Pharmacovigilance Programme of India (PvPI), and Materiovigilance Programme of India (MvPI).<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>Centre of Excellence in Biological Therapeutics at NIPER Hajipur Organised a National Level One-Day Symposium on \u201cGood Laboratory Practice for Enhancing R&amp;D Capabilities in Biological Therapeutics\u201d on 31.1.2025.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>NIPER Hajipur achieved a placement record of 84.25% for the graduating batch of 2025, reflecting strong industry linkage and employability of its graduates.<\/strong><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>NIPER Hyderabad<\/strong><\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>NIPER Hyderabad earned national recognition for its significant contribution to the NADA Project, advancing the mission of Clean Sports and Public Health.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>NIPER Hyderabad successfully hosted an Industry\u2013Academia Meet in collaboration with the Indian Drug Manufacturers\u2019 Association (IDMA) on 17.9.2025.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>NIPER Hyderabad organised conference on Innovative Processes for Bulk Drugs (IPBD- 2025) on 27-28.3.2025. The conference was organised as a part of the activities towards the establishment of Centre of Excellence (CoE) in Bulk Drugs at NIPER Hyderabad.<\/strong><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>NIPER Kolkata<\/strong><\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>The Institute conducted one Invited Talk on \u201cContinuous manufacturing of Pharmaceuticals\u201d on 25.4.2025.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>NIPER Kolkata conducted an Invited Talk on \u201cSmart Eating, Healthy Living: Building a Culture of Balanced Food of Choices to Prevent Obesity\u201d on 2.9.2025.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>The Institute organised a Workshop on R&amp;D Proposal Writing on 13.10.2025.<\/strong><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>NIPER Mohali<\/strong><\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>NIPER Mohali has established\u00a0Dr Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD) on 4.9.2025.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>NIPER Mohali has conducted two trainings under Indian Technical and Economic Cooperation (ITEC) &#8211; Ministry of External Affairs, in the field of Pharmaceuticals.<\/strong><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>NIPER Raebareli.<\/strong><\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>NIPER Raebareli has organised the National Symposium on \u201cInnovations on Age-appropriate Therapeutics for the Elderly: Challenges &amp; Opportunities\u201d on 18.8.2025 at Lucknow in association with Sun Pharma Science Foundation.<\/strong><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>13.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Scheme for Promotion of Research and Innovation in Pharma MedTech Sector (PRIP)<\/strong><\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li><span style=\"color: #3366ff;\"><strong>The scheme aims to strengthen India\u2019s pharmaceutical and MedTech ecosystem by shifting focus from generic manufacturing to innovation-led growth through support for research, product development, and industry\u2013academia collaboration.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>The Scheme has two components viz., Component A and Component B.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>Under Component A, seven Centres of Excellence have been established, one at each National Institutes of Pharmaceutical Education and Research, in identified areas of specialisation with an overall outlay of \u20b9700 crore.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>As on November 2025, the CoEs have approved 111 research projects to be taken up under the scheme. Further, forty-six research papers have been published and six patents were filed.<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff;\"><strong>Under Component B, financial assistance will be provided to industries, MSMEs, start-ups for research in the identified priority areas in Pharma-MedTech sector.<\/strong><\/span><\/li>\n<\/ul>\n<ul>\n<li style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>Under Component B, the amended scheme and guidelines were notified on 1.10.2025 and applications were invited through an online portal.<\/strong><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"color: #3366ff;\"><strong>The evaluation of the applications\/projects received is currently underway, and the release of funds to eligible applicants is expected to commence within the current financial year.<\/strong><\/span><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>India Medtech Expo 2025 showcased End-To-End Medtech Ecosystem Reinforcing India\u2019s Position as a Global Medtech Innovation Hub Pradhan Mantri Bhartiya Janaushadhi Pariyojana Register Sales of \u20b9 1409.32 cr till November 2025; Online Web Portal revamped for seamless form filling and Live Tracking with Geo-Tagging; Under PLI Scheme for Pharmaceuticals, \u20b940,294cr worth investment made; 726 APIs &hellip;<\/p>\n","protected":false},"author":2,"featured_media":16471,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-16470","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-education-news"],"_links":{"self":[{"href":"https:\/\/theeducationoverview.in\/index.php?rest_route=\/wp\/v2\/posts\/16470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/theeducationoverview.in\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/theeducationoverview.in\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/theeducationoverview.in\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/theeducationoverview.in\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16470"}],"version-history":[{"count":2,"href":"https:\/\/theeducationoverview.in\/index.php?rest_route=\/wp\/v2\/posts\/16470\/revisions"}],"predecessor-version":[{"id":16473,"href":"https:\/\/theeducationoverview.in\/index.php?rest_route=\/wp\/v2\/posts\/16470\/revisions\/16473"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/theeducationoverview.in\/index.php?rest_route=\/wp\/v2\/media\/16471"}],"wp:attachment":[{"href":"https:\/\/theeducationoverview.in\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/theeducationoverview.in\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/theeducationoverview.in\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}